Thibaud Eckenschwiller

Zambon Co. SpA operates as an industrial holding company with interests in pharmaceuticals and chemicals. The company was founded by Gaetano Zambon on November 11, 1906 and is headquartered in Bresso, Italy.

Zambon Group SpA engages in the production of chemicals and medicines. The company was founded in 1906 and is headquartered in Bresso, Italy.

GEFIM SpA provides real estate investment and management services. The firm specializes in development, rehabilitation, and management of industrial spaces within urban cities and metropolitan areas. Its focuses on areas encompass project financing, economic feasibility studies, financial planning, administrative and technical support, and property acquisition. It also engages in contracting operations, focuses on the construction and design of industrial buildings and facilities. The company was founded by Cavaliere Paolo Ponchia in 1880 and is headquartered in Turin, Italy.

Enaz Srl functions as an investment holding Italian company. The private company is based in Milan, Italy.

Iava Srl is an investment holding Italian company. The private company is based in Milan, Italy.

Itaz Srl is an investment holding Italian company. The private company is based in Milan, Italy.

Part of Gefim SpA, Cleops SRL is an investment holding Italian company. The company is based in Milan, Italy.

Secofind SIM SpA engages in the provision of investment services. It offers wealth protection, optimization, and management. The company was founded in 2000 and is headquartered in Milan, Italy.

Part of GEFIM SRL, Zambon Immobiliare SpA is an Italian company that provides real estate services. The company is based in Bresso, Italy.

Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy.

Bios SpA provides diagnostic laboratory services. The firm conducts multi-specialist medical treatment solutions through its facilities which include anti-thrombosis center, center for the diagnostic and treatment of hypertension, treatment of headache, and pregnancy monitoring center. It also provides emergency services through its department of emergency laboratory analysis and the service of rapid diagnostics as well as consultations on medicine in the workplaces, preventive medicine, and home care. The company was founded in 1974 and is headquartered in Rome, Italy.

Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France.

Associazione fra le società italiane per azioni operates as an organization which deals with issues concerning the interests and the development of the Italian economy. Its activities deals with the improvement and promotion of problems and solutions in tax and legislation, corporate laws, business operations and competition, capital and listed company markets, economic analysis, and institutional reports. The company was founded on November 22, 1910 and is headquartered in Rome, Italy.

Castello SGR SpA (Castello) is an asset management firm headquartered in Milan, Italy. The firm was founded in 2007 and was acquired by Anima Holding SpA (BIT: ANIM) in 2023. Castello engages in the design and execution of real estate investment strategies for national and international investors who want to allocate their capital on the Italian real estate market. Investors of Castello SGR funds include financial institutions, insurance companies, private equity funds, hedge funds, pension funds, family offices, individual investors, both national and international. Castello is a signatory to the UN Principles for Responsible Investment (UNPRI).

Farmabios SpA engages in the manufacture and marketing of active ingredients for pharmaceutical applications. It offers oral cephalosporins, steroids hormones, highly potent substances, multipurpose plant for steroids, sterile cephalosporins, sterile steroids, and antineoplastics. The company was founded in 1961 and is headquartered in Gropello Cairoli, Italy.

Cassa di Compensazione e Garanzia SpA engages in the provision of clearing and settlement services. It offers a broad range of trading venues and asset classes which include shares, warrants and convertible bonds listed on MTA market; stock, index futures and options listed on IDEM Equity; and closed-end funds. The company was founded on March 31, 1992 and is headquartered in Rome, Italy.

Istituto Atesino di Sviluppo SpA (ISA) is a private equity firm founded in 1929. The firm is headquartered in Trento, Italy.

Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry.

NTC SRL manufactures generic drugs, nutraceutical and pharmaceutical products. It develops and produces generic drugs for specialist therapies, innovative medical devices and high quality food supplements. The company was founded by Nicola Travierso in 1997 and is headquartered in Milan, Italy.

Euronext Growth Milan engages in the organization and management of the Italian stock exchange. Its activities include: overseeing transaction activities; defining the rules and procedures for admission and listing on the market for issuing companies, as well as for intermediaries; and the supervision of listed company disclosures. The company was founded in 1997 and is headquartered in Milan, Italy.

Peptomyc SL develops cell penetrating peptides targeting the Myc oncoprotein for cancer treatment. The company was founded by Marie-Eve Beaulieu and Laura Soucek on December 16, 2014 and is headquartered in Barcelona, Spain.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

EuropeanIssuers operates as an an association representing the interests of publicly quoted companies. The company is headquartered in Brussels, Belgium.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy.

Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy.

Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom.

Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy.

Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway.

Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million.